Raffaella Cascella (Domenica Megalizzi)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 11

Top Topics

Rheumatoid Arthritis

Machine Learning

Coronavirus Disease

Dna Methylation

Top Venues

Journal of personalized medicine

Electrophoresis

This page only lists publications with an associated author ORCID identifier.

Publications

Stefania Zampatti, Cristina Peconi, Raffaella Cascella, Giulia Calvino, Giulia Trastulli, Raffaella Cascella, Claudia Strafella, Carlo Caltagirone, Emiliano Giardina
Innovations in Medicine: Exploring ChatGPT's Impact on Rare Disorder Management. Genes 15 (4) (2024)
Stefania Zampatti, Cristina Peconi, Raffaella Cascella, Giulia Calvino, Giulia Trastulli, Raffaella Cascella, Claudia Strafella, Carlo Caltagirone, Emiliano Giardina
Innovations in Medicine: Exploring ChatGPT's Impact on Rare Disorder Management. Genes 15 (4) (2024)
Stefania Zampatti, Cristina Peconi, Raffaella Cascella, Giulia Calvino, Giulia Trastulli, Raffaella Cascella, Claudia Strafella, Carlo Caltagirone, Emiliano Giardina
Innovations in Medicine: Exploring ChatGPT's Impact on Rare Disorder Management. Genes 15 (4) (2024)
Stefania Zampatti, Cristina Peconi, Raffaella Cascella, Giulia Calvino, Giulia Trastulli, Raffaella Cascella, Claudia Strafella, Carlo Caltagirone, Emiliano Giardina
Innovations in Medicine: Exploring ChatGPT's Impact on Rare Disorder Management. Genes 15 (4) (2024)
Domenica Megalizzi, Giulia Trastulli, Valerio Caputo, Luca Colantoni, Carlo Caltagirone, Claudia Strafella, Raffaella Cascella, Emiliano Giardina
Epigenetic profiling of the D4Z4 locus: Optimization of the protocol for studying DNA methylation at single CpG site level. Electrophoresis (2023)
Valerio Caputo, Raffaella Cascella, Carlo Fabrizio, Andrea Termine, Luca Colantoni, Cristina Bax, Juliette Gimenez, Mauro Monforte, Giorgio Tasca, Enzo Ricci, Carlo Caltagirone, Emiliano Giardina, Raffaella Cascella, Claudia Strafella
D4Z4 Methylation Levels Combined with a Machine Learning Pipeline Highlight Single CpG Sites as Discriminating Biomarkers for FSHD Patients. Cells 11 (24) (2022)
Valerio Caputo, Raffaella Cascella, Carlo Fabrizio, Andrea Termine, Luca Colantoni, Cristina Bax, Juliette Gimenez, Mauro Monforte, Giorgio Tasca, Enzo Ricci, Carlo Caltagirone, Emiliano Giardina, Raffaella Cascella, Claudia Strafella
D4Z4 Methylation Levels Combined with a Machine Learning Pipeline Highlight Single CpG Sites as Discriminating Biomarkers for FSHD Patients. Cells 11 (24) (2022)
Carlo Fabrizio, Andrea Termine, Valerio Caputo, Raffaella Cascella, Giulia Calvino, Giulia Trastulli, Arcangela Ingrascì, Simona Ferrante, Cristina Peconi, Angelo Rossini, Antonino Salvia, Carlo Caltagirone, Claudia Strafella, Emiliano Giardina, Raffaella Cascella
Analysis of Genetic Variants Associated with COVID-19 Outcome Highlights Different Distributions among Populations. Journal of personalized medicine 12 (11) (2022)
Valerio Caputo, Raffaella Cascella, Carlo Fabrizio, Andrea Termine, Luca Colantoni, Cristina Bax, Juliette Gimenez, Mauro Monforte, Giorgio Tasca, Enzo Ricci, Carlo Caltagirone, Emiliano Giardina, Raffaella Cascella, Claudia Strafella
D4Z4 Methylation Levels Combined with a Machine Learning Pipeline Highlight Single CpG Sites as Discriminating Biomarkers for FSHD Patients. Cells 11 (24) (2022)
Carlo Fabrizio, Andrea Termine, Valerio Caputo, Raffaella Cascella, Giulia Calvino, Giulia Trastulli, Arcangela Ingrascì, Simona Ferrante, Cristina Peconi, Angelo Rossini, Antonino Salvia, Carlo Caltagirone, Claudia Strafella, Emiliano Giardina, Raffaella Cascella
Analysis of Genetic Variants Associated with COVID-19 Outcome Highlights Different Distributions among Populations. Journal of personalized medicine 12 (11) (2022)
Valerio Caputo, Raffaella Cascella, Carlo Fabrizio, Andrea Termine, Luca Colantoni, Cristina Bax, Juliette Gimenez, Mauro Monforte, Giorgio Tasca, Enzo Ricci, Carlo Caltagirone, Emiliano Giardina, Raffaella Cascella, Claudia Strafella
D4Z4 Methylation Levels Combined with a Machine Learning Pipeline Highlight Single CpG Sites as Discriminating Biomarkers for FSHD Patients. Cells 11 (24) (2022)